These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 550288)

  • 1. [Synergistic action of amphotericin B and 5-fluorocytosine on Fonsecaea pedrosoi].
    de Resende MA
    Rev Inst Med Trop Sao Paulo; 1979; 21(6):344-6. PubMed ID: 550288
    [No Abstract]   [Full Text] [Related]  

  • 2. [Susceptibility tests of Fonsecaea pedrosoi strains to the combination of thiabendazole and amphotericin B "in vitro"].
    deRosanda MA
    Rev Inst Med Trop Sao Paulo; 1979; 21(6):347-9. PubMed ID: 550289
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent developments in the therapy of chromoblastomycosis.
    Ferreira Lopes C
    Bull Pan Am Health Organ; 1981; 15(1):58-64. PubMed ID: 7248640
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitivity of Candida to 5-fluorocytosine and amphotericin B].
    Pawlik B; Budak A; Macura A; Laskownicka Z
    Med Dosw Mikrobiol; 1978; 30(1):43-8. PubMed ID: 692181
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination of 5-fluorocytosine and amphotericin B in the treatment of chromomycosis].
    Lopes CF; Resende MA; Alvarenga RJ; Moreira YK
    Med Cutan Ibero Lat Am; 1979; 7(1-3):1-7. PubMed ID: 398931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chromomycosis with a combination of 5-fluorocytosine and thiabendazole. Apropos of a Zairian case due to Fonsecaea pedrosoi].
    De Clercq D; Kakiesse M; De Vroey C; Mazebo P
    Ann Soc Belg Med Trop; 1985; 65(1):95-7. PubMed ID: 4004379
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of Scopulariopsis brevicaulis to some antimicrobial agents.
    Sekhon AS
    Mycopathologia; 1975 Dec; 57(3):177-9. PubMed ID: 1240599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
    Andrade TS; Castro LG; Nunes RS; Gimenes VM; Cury AE
    Mycoses; 2004 Jun; 47(5-6):216-21. PubMed ID: 15189187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
    J Antimicrob Chemother; 1984 Jul; 14(1):1-8. PubMed ID: 6480540
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for sequential action of amphotericin B and 5-fluorocytosine on Canida albicans ATCC 11651.
    Beggs WH; Andrews FA; Sarosi GA
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):557-60. PubMed ID: 322227
    [No Abstract]   [Full Text] [Related]  

  • 11. Fonsecaea pedrosoi: lipid composition and determination of susceptibility to amphotericin B.
    Gomes MH; Resende MA
    Can J Microbiol; 1992 Mar; 38(3):209-14. PubMed ID: 1393822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of synergistic interactions between amphotericin B and flucytosine.
    Beggs WH
    J Antimicrob Chemother; 1986 Apr; 17(4):402-4. PubMed ID: 3519560
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Fluorocytosine--current status with special references to mode of action and drug resistance.
    Polak A
    Contrib Microbiol Immunol; 1977; 4():158-67. PubMed ID: 342192
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous infection with phialophora richardsiae and its susceptibility to 5-fluorocytosine, amphotericin B and miconazole.
    Corrado ML; Weitzman I; Stanek A; Goetz R; Agyare E
    Sabouraudia; 1980 Jun; 18(2):97-104. PubMed ID: 7423334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B.
    Poirriez J; Breuillard F; Francois N; Fruit J; Sendid B; Gross S; Dei-Cas E
    Am J Trop Med Hyg; 2000; 63(1-2):61-3. PubMed ID: 11357997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 18. Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination.
    Lauer BA; Reller LB; Schröter GP
    J Antimicrob Chemother; 1978 Jul; 4(4):375-80. PubMed ID: 690038
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of chromoblastomycosis with amphotericin B and 5-fluorocytosine].
    Astorga E; Bonilla E; Martínez C; Mura W
    Med Cutan Ibero Lat Am; 1981; 9(2):125-8. PubMed ID: 7026925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
    Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.